ZR2 Bioenergy Ltd Board of Directors
Get the latest insights into the leadership at ZR2 Bioenergy Ltd. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Jimmy Olsson | Chairman & Managing Director |
| Mr. Sunil Kondiba Kalhapure | Ind. Non-Executive Director |
| Mr. Nilesh Jayant Jain | Non Exe.Non Ind.Director |
| Mr. Nirupama Charuhas Khandke | Non Exe. & Ind. Director |
ZR2 Bioenergy Ltd Share price
ZR2
398
7.95 (-1.96%)Last updated on 4 Sep, 2025 | 15:45 IST
BUYSELL
Today's High
405.00
Today's Low
375.60
52 Week Low
255.45
52 Week High
540.60
The current prices are delayed, login to your account for live prices
LoginZR2 Bioenergy Ltd FAQs
The board at ZR2 Bioenergy Ltd consists of experienced professionals, including Mr. Jimmy Olsson , Mr. Sunil Kondiba Kalhapure , and others, overseeing the company’s strategic and corporate governance.
Directors at ZR2 Bioenergy Ltd are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Jimmy Olsson is the current chairman at ZR2 Bioenergy Ltd.
Executive directors at ZR2 Bioenergy Ltd are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, ZR2 Bioenergy Ltd adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At ZR2 Bioenergy Ltd, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.